Sabby Management’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-40,344
| Closed | -$887K | – | 124 |
|
|
2021
Q3 | $887K | Buy |
+40,344
| New | +$887K | 0.12% | 48 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 106 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 112 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 85 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 90 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 72 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 73 |
|
|
2019
Q4 | – | Sell |
-185,800
| Closed | -$593K | – | 63 |
|
|
2019
Q3 | $593K | Sell |
185,800
-168,913
| -48% | -$539K | 0.32% | 17 |
|
|
2019
Q2 | $1.27M | Sell |
354,713
-326,787
| -48% | -$1.17M | 1.6% | 10 |
|
|
2019
Q1 | $2.48M | Sell |
681,500
-251,550
| -27% | -$916K | 1.19% | 3 |
|
|
2018
Q4 | $2.8M | Buy |
933,050
+131,808
| +16% | +$395K | 0.62% | 7 |
|
|
2018
Q3 | $3.88M | Buy |
+801,242
| New | +$3.88M | 0.5% | 8 |
|
|
2015
Q4 | – | Sell |
-10,558
| Closed | -$58K | – | 191 |
|
|
2015
Q3 | $58K | Sell |
10,558
-201,459
| -95% | -$1.11M | ﹤0.01% | 191 |
|
|
2015
Q2 | $1.2M | Buy |
+212,017
| New | +$1.2M | 0.04% | 84 |
|